바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

기계환기폐렴의 원인균 진단에서 인공기도 흡인액을 이용한 Multiplex PCR과 세균배양 결과의 비교

Multiplex PCR of Endotracheal Aspirate for the Detection of Pathogens in Ventilator Associated Pneumonia

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2008, v.64 no.3, pp.194-199
송주한 (중앙의대)
최재철 (중앙대학교)
명순철 (중앙대학교)
박인원 (중앙대학교)
최병휘 (중앙대학교)
김재열 (중앙대학교)
신종욱 (중앙대학교)
최송호 (중앙의대)
전은주 (중앙의대)
강형구 (중앙의대)
이혜민 (중앙의대)
조성근 (중앙의대)
  • 다운로드 수
  • 조회수

Abstract

Background: Early identification of pathogens can improve the prognosis of patients with ventilator associated pneumonia (VAP). In the present study, we evaluated the feasibility of performing multiplex PCR for endotracheal aspirates to detect three important pathogens (P. aeruginosa, K. pneumoniae and MRSA) in patients with VAP. Methods: The endotracheal aspirates of 24 patients were collected within 24 hours of the diagnosis of VAP for performing multiplex PCR. Forward and reverse primers were designed to target the specific site of each pathogen (the oprL gene for P. aeruginosa, 16S rRNA for K. pneumoniae and the mec gene for MRSA). We analyzed the clinical data of the VAP patients, including the culture reports for the endotracheal aspirates. Results: Twenty-four patients (M:F=18:6, mean age=70±11) with VAP were enrolled. Pathogens were isolated from 11 patients (P. aeruginosa in 2, K. pneumoniae in 1, MRSA in 2, other enteric Gram negative bacilli in 3, S.pneumoniae in 2 and mixed infection in 1). Multiplex PCR detected three cases of P.aeruginosa (2 cases coincided with the culture reports) and four cases of K. pneumoniae (1 matched with the culture report). PCR detected two MRSA cases, which did not coincide with the culture reports. Conclusion: Multiplex PCR of the endotracheal aspirate showed some ability to detect Gram negative bacilli, although caution is required when interpreting the results.

keywords
Multiplex PCR, Ventilator associated pneumonia, P. aeruginosa, K. pneumoniae, MRSA

참고문헌

1.

1. Craven DE, Palladino R, McQuillen DP. Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect Dis Clin North Am 2004;18:939-62.

2.

2. American Thoracic Society; Infectious Disease Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare- associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.

3.

3. Rosenthal VD, Guzman S, Migone O, Safdar N. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.Am J Infect Control 2005;33:157-61.

4.

4. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest 1995;108:1S-16S.

5.

5. Meduri GU. Diagnosis and differential diagnosis of ventilator-associated pneumonia. Clin Chest Med 1995;16:61-93.

6.

6. Andrews CP, Coalson JJ, Smith JD, Johanson WG Jr.Diagnosis of nosocomial bacterial pneumonia in acute,diffuse lung injury. Chest 1981;80:254-8.

7.

7. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia.Chest 1992;102:557S-64S.

8.

8. Baselski VS, el-Torky M, Coalson JJ, Griffin JP. The standardization of criteria for processing and interpreting laboratory specimens in patients with suspected ventilator-associated pneumonia. Chest 1992;102:571S-9S.

9.

9. Moon DS, Lim CM, Pai CH, Kim MN, Chin JY, Shim TS, et al. Study for diagnostic efficacy of minibronchoalveolar lavage in the detection of etiologic agents of ventilator-associated pneumonia in patients receiving antibiotics. Tuberc Respir Dis 1999;47:321-30.

10.

10. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator-associated pneumonia. Chest 2006;130:597-604.

11.

11. Duan K, Lafontaine ER, Majumdar S, Sokol PA. RegA,iron, and growth phase regulate expression of the Pseudomonas aeruginosa tol-oprL gene cluster. J Bacteriol 2000;182:2077-87.

12.

12. Pingle MR, Granger K, Feinberg P, Shatsky R, Sterling B, Rundell M, et al. Multiplexed identification of blood-borne bacterial pathogens by use of a novel 16S rRNA gene PCR-ligase detection reaction-capillary electrophoresis assay. J Clin Microbiol 2007;45:1927-35.

13.

13. Ito T, Kuwahara K, Hiramatsu K. Staphylococcal cassette chromosome mec (SCC mec) analysis of MRSA.Methods Mol Biol 2007;391:87-102.

14.

14. Ranes JL, Gordon SM, Chen P, Fatica C, Hammel J,Gonzales JP, et al. Predictors of long-term mortality in patients with ventilator-associated pneumonia. Am J Med 2006;119:897.e13-9.

15.

15. Luna CM, Aruj P, Niederman MS, Garzon J, Violi D,Prignoni A, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006;27:158-64.

16.

16. Stralin K, Tornqvist E, Kaltoft MS, Olcen P, Holmberg H. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol 2006;44:643-5.

17.

17. Rello J, Lorente C, Diaz E, Bodi M, Boque C,Sandiumenge A, et al. Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation.Chest 2003;124:2239-43.

18.

18. Cowen JS, Kelley MA. Errors and bias in using predictive scoring systems. Crit Care Clin 1994;10:53-72.

19.

19. Escarce JJ, Kelley MA. Admission source to the medical intensive care unit predicts hospital death independent of APACHE II score. JAMA 1990;124:2389-94.

20.

20. Knaus WA, Wagner DP, Draper EA, Zimmerman JE,Bergner M, Bastos PG, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619-36.

Tuberculosis & Respiratory Diseases